Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells
T cells equipped with chimeric antigen receptors (CAR T cells) have recently provided promising advances as a novel immunotherapeutic approach for cancer treatment. CAR T cell therapy has shown stunning results especially in B-cell malignancies; however, it has shown less success against solid tumor...
Main Authors: | Reza Elahi, Elnaz Khosh, Safa Tahmasebi, Abdolreza Esmaeilzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01717/full |
Similar Items
-
Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma
by: Abdolreza Esmaeilzadeh, et al.
Published: (2020-03-01) -
Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies
by: Faizan Ahmad
Published: (2020-01-01) -
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
by: Mohamed-Reda Benmebarek, et al.
Published: (2019-03-01) -
Antigen-specific T cell activation independently of the MHC: chimeric antigen receptor (CAR)-redirected T cells.
by: Hinrich eAbken, et al.
Published: (2013-11-01) -
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
by: Stefan Stoiber, et al.
Published: (2019-05-01)